Title
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial (British Journal of Cancer, (2019), 120, 10, (959-967), 10.1038/s41416-019-0435-4)
Date Issued
31 March 2020
Access level
open access
Resource Type
corrigendum
Author(s)
Ribi K.
Luo W.
Colleoni M.
Karlsson P.
Chirgwin J.
Aebi S.
Jerusalem G.
Neven P.
Di Lauro V.
Ruhstaller T.
Abdi E.
Biganzoli L.
Müller B.
Barbeaux A.
Graas M.P.
Rabaglio M.
Francis P.A.
Foukakis T.
Pagani O.
Graiff C.
Vorobiof D.
Maibach R.
Di Leo A.
Gelber R.D.
Goldhirsch A.
Coates A.S.
Regan M.M.
Bernhard J.
Publisher(s)
Springer Nature
Abstract
The ClinicalTrials.gov Identifier was incorrectly listed as NCT00651456. The correct identifier is listed below. Clinical trial information Clinical trial information: NCT00553410.
Start page
1119
Volume
122
Issue
7
Language
English
OCDE Knowledge area
Farmacología, Farmacia
Oncología
Scopus EID
2-s2.0-85078623828
PubMed ID
Source
British Journal of Cancer
ISSN of the container
00070920
Sources of information:
Directorio de Producción Científica
Scopus